Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 16 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

c-Myc overexpression associated with cancer in Barrett's

c-Myc overexpression is strongly associated with the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus, reports the latest Diseases of the Esophagus.

News image

fiogf49gjkf04

Barrett's esophagus develops as a result of a severe esophageal mucosa injury from gastroesophageal reflux.

Barrett's esophagus is a premalignant lesion and plays an important role in the development of esophageal adenocarcinoma.

Dr Schmidt and colleagues from Brazil determined the expression of the proto-oncogene c-Myc in patients with Barrett's esophagus, and esophageal adenocarcinoma.

The research team evaluated the prevalence of such expression in relation to the metaplasia-dysplasia-adenocarcinoma sequence.

c-Myc overexpression occurred in 37% of Barrett's esophagus
Diseases of the Esophagus

The team identified several genetic alterations in the process that transforms a normal cell into a tumorous one.

In the development of human tumors, one of the most important genes is the proto-oncogene c-Myc.

The researchers then determined c-Myc protein expression by immunohistochemical analysis in 4 different groups.

The team reported that there were 31 patients with normal tissue, and 43 patients with Barrett's esophagus without dysphasia.

The team also identified 11 patients with dysplasia in Barrett's esophagus, and 37 patients with esophageal adenocarcinoma.

The material was obtained from esophageal biopsies or the dissection of patient esophagectomy specimens.

The researchers analyzed demographic and endoscopic data that included sex, age, race and intestinal metaplasia extension.

In addition the team assessed morphologic and histopathologic tumor characteristics.

The research team evaluated deep tumor invasion, lymph node status, and tumor differentiation.

The c-Myc expression was assessed using the Immunoreactive Scoring System.

The team found overexpression of c-Myc in only 10% of normal tissue specimens.

c-Myc overexpression occurred in 37% of Barrett's esophagus patients, and 46% of Barrett's esophagus patients with dysphasia.

In adenocarcinoma samples, the team observed c-Myc over expression in 73%.

There was no significant statistical difference among these groups.

The research team identified no correlation when the c-Myc expression was compared with morphologic and histologic tumor features or endoscopic data.

However, linear correlation of c-Myc overexpression along the metaplasia-dysplasia-adenocarcinoma sequence was observed.

Dr Schmidt's team concluded, "This study demonstrates a significant increase in the expression of c-Myc in Barrett's esophagus dysplasia and adenocarcinoma in relation to the control group.

"We also found a linear progression of this gene expression in this sequence."

"These results point out the importance of this marker in the development of esophageal adenocarcinoma from Barrett's esophagus."

Dis Esophagus 2007:20(3): 212-6
24 May 2007

Go to top of page Email this page Email this page to a colleague

 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 20 December 2017 
Management of abnormal liver blood tests
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure
 06 December 2017 
Preventing hepatic encephalopathy-related readmissions
 05 December 2017 
Thiopurines and colorectal cancer in IBD
 05 December 2017 
Childhood obesity into adulthood

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us